Teddi Mellencamp is opening up about her Stage 4 cancer battle, including her chances of surviving. Find out more.

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...

The programme has already given thousands of patients better access to a personalised vaccine for bowel cancer.

A review of modern treatment strategies for skin cancer includes recommendations for addressing irAEs with immunotherapy for nonmelanoma skin cancers.

A new systematic review reveals promising results for oncolytic viral therapy in treating nonmelanoma skin cancers and ...

Patients with advanced skin cancer will soon be able to test a new vaccine as part of a drive to speed up the development of ...

The NHS is partnering with UK life sciences company Scancell to do clinical trials of an ambitious new vaccine to treat skin cancer, as the government seeks to boost Britain’s position as a global ...

Mellencamp was first diagnosed with melanoma in 2022, and the cancer has since spread to other parts of her body, making it Stage 4.

Patients with advanced skin cancer in England are set to be fast-tracked into trials of a new cancer vaccine, following the expansion of a world-leading NHS programme. The needle-free injection, which ...

Gabrielle Knipe describes her shock at being diagnosed with skin cancer at the age of 26 and how it changed her outlook on ...